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I. INTRODUCTION
Public health organizations have been fighting the “war on cigarettes” for
years, trying to put an end to the tobacco industry that is credited with
causing an estimated 100 million deaths over the last century.1 In the United
States alone tobacco use continues to be the leading cause of preventable
disease and death, with cigarette smoking causing about one in every five
deaths each year, totaling over 480,000 deaths annually.2 Recently, a new
product has entered the market that some fear will undo the progress made
against nicotine addiction and smoking. Electronic cigarettes, also called ecigarettes, vapes, vape pens, or ENDS (electronic nicotine delivery systems),
first entered commercial markets in the mid-2000s.3 Since that time,
countries and regulatory agencies have grappled with how best to define and
regulate the product. E-cigarette regulation is a difficult area because of the
competing public health concerns and implications surrounding the product’s
use. Proponents of e-cigarettes argue that the devices serve an important
harm-reduction function. For chronic smokers, switching from traditional
cigarettes to e-cigarettes can arguably reduce the amount of toxins consumed
and serve as a gateway to cessation.4 Additionally, e-cigarettes can greatly
reduce the societal harm associated with second-hand smoke inhalation
because the devices discharge a less-harmful vapor. However, others argue
that e-cigarettes pose a significant public health risk because they facilitate
nicotine addiction, “re-normalize and re-glamorize smoking to vulnerable
youth and developing world populations,”5 and are both accessible and
appealing to a young population.6 Countries attempting to regulate these
new products must sort e-cigarettes into one of the following categories:
medical device, drug, tobacco product, or regular consumer product.

1

Countries Vindicate Cautious Stance on E-Cigarettes, 92 BULL. OF THE WORLD HEALTH
ORG. 856, 857 (2014), http://www.who.int/bulletin/volumes/92/12/14-031214/en/.
2
Tobacco Related Mortality, CDC, https://www.cdc.gov/tobacco/data_statistics/fact_shee
ts/health_effects/tobacco_related_mortality/index.htm.
3
Marie-Claude Tremblay et al., Regulation Profiles of E-cigarettes in the United States: A
Critical Review with Qualitative Synthesis, 13 BMC MED. 1, 1–6 (2015) (evaluating current
federal and state e-cigarette regulations in the United States).
4
See Muhammad Aziz Rahman et al., Electronic Cigarettes: Patterns of Use, Health
Effects, Use in Smoking Cessation and Regulatory Issues, 12 TOBACCO INDUCED DISEASES 1,
1–18 (2014) (evaluating the regulation and major public health concerns of e-cigarettes).
“One study showed [e-cigarettes] to be as effective as nicotine patches in helping smokers to
quit and superior to nicotine patches in reducing the number of cigarettes individuals
smoked.” Id. at 2.
5
Id.
6
Tremblay et al., supra note 3, at 1.
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Furthermore they must choose a regulatory scheme that best mitigates the
risk to their population while maximizing potential harm-reduction benefits.
Part II of this Note will discuss the background of e-cigarettes, including
the product design, market history, growing social use among teenagers, and
health effects. Then this Note will compare the current regulatory schemes,
including the framework for regulation promulgated by the World Health
Organization. Part III will discuss benefits and shortcomings of regulation
against a scheme of little or no regulation. Part IV will offer concluding
remarks.
II. BACKGROUND
A. Product Design: How e-Cigarettes Work
E-cigarettes are “battery-powered devices that vaporize a flavored
propylene glycol or glycerin solution, with or without nicotine, to simulate
cigarette smoking.”7 The vapor is inhaled as one would inhale cigarette
smoke. Users will experience a nicotine high similar to that of cigarette or
hookah tobacco.8 Nicotine has been described by users as a cure all. “When
you are sleepy it wakes you; when you are anxious, it relaxes you; when you
are hungry, it takes your hunger away.”9
Originally, the products were designed to resemble traditional cigarettes.
Now, users can choose from a broad range of designs. Some are slim,
resembling a pen or cigar; others are bulkier and closer to the size of a pocket
flask.
Once users have obtained the e-cigarette, they can then buy the liquid that
will be vaporized. Although the designs vary, the user will generally put a few
drops of liquid into the device which will then turn to vapor via heat by a coil.
The liquid generally contains approximately 12% of nicotine, but higher
concentrations are available. Liquid with no nicotine is usually geared toward
users who are under eighteen and unable to buy the nicotine product. The
pleasant flavors of the liquid, akin to the flavored tobacco in a hookah pipe, are
what make the product appealing. Users can choose from a wide array of
flavors, such as cinnamon roll, lemonade, fruit roll-up, gusher, coffee, coconut,
7

Id.
See Nicotine Addiction and Your Health, U.S. DEPARTMENT OF HEALTH AND HUMAN
SERVICES, http://betobaccofree.hhs.gov/health-effects/nicotine-health/ (“When you use
tobacco products, nicotine is quickly absorbed into your bloodstream. Within 10 seconds of
entering your body, the nicotine reaches your brain. It causes the brain to release adrenaline,
creating a buzz of pleasure and energy.”).
9
Eliza Gray, Electronic Cigarettes: The Future of Smoking, TIME (Sept. 30, 2013), http://
content.time.com/time/subscriber/article/0,33009,3152409-3,oo.html.
8
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ice cream, and apple juice. An e-liquid cartridge, ranging in price from $5 at
the gas station to $30 for an upscale brand at a specialty store, can last
anywhere from a month to a day depending on how often users vape. Because
the nicotine is contained in the liquid, regulation may be more heavily focused
on the liquid than on the e-cigarette device itself. However, product design
regulations governing how hot the coil can heat to will also be necessary.
B. Evolution of the e-Cigarette Market
Chinese pharmacist Hon Lik patented the first e-cigarette in 2003. A
smoker himself, Lik lost his father to lung cancer and was searching for a
safer way to get a nicotine fix.10 E-cigarettes became available in both U.S.
and European markets approximately four years later.11 Since e-cigarettes’
introduction to the market demand has exploded. While China is still the
biggest producer of e-cigarettes and e-liquids, in 2013, the industry was
worth $1.8 billion in the U.S. alone.12 In 2014, that number increased to $2.5
billion, and in 2015, to $3.5 billion.13 The “e-cigarette global industry is
projected to reach $10 billion by 2017.”14
Large transnational tobacco companies not wanting to lose their grip on
the $800 billion tobacco industry began investing in e-cigarette technology
almost immediately. The current e-cigarette market is mostly split between
e-cigarettes made by Big Tobacco,15 valued at $1.5 billion, and vaporizers
that use refillable liquid nicotine from small manufacturers, valued at $2
billion.16 While the e-cigarette market was initially “dominated by
companies with no links to the tobacco industry, it is increasingly owned by
the tobacco industry.” “All main transnational tobacco companies sell
ENDS,” and one company is even “launching legal proceedings over patents
against its rivals as they become increasingly aggressive in the battle for the
fast-growing e-cigarette market.”17 The tobacco industry is “trying to regain
the respectability it lost long ago by appearing to offer a solution with one

10

Id.
Rahman et al., supra note 4.
12
Id.
13
Tripp Mickle, FDA Cloud Hangs Over Vape Shops, WALL ST. J. (July 7, 2015), https://
www.wsj.com/articles/SB10130211234592774869404581088451777513530.
14
Tremblay et al., supra note 3, at 1.
15
For more on Big Tobacco, see, Mark Schapiro, Big Tobacco, NATION (Apr. 18, 2002),
https://www.thenation.com/article/big-tobacco/.
16
FDA Cloud Hangs Over Vape Shops, supra note 13.
17
Electronic Nicotine Delivery Systems, WHO FRAMEWORK CONVENTION ON TOBACCO
CONTROL 1, 8 (July 8, 2014), http://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10-en.pdf.
11
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hand, while continuing to create mass destruction with the other.”18 Now,
“e-cigarettes are sold at Walmart, vaped by Katherine Heigl and Leonardo
DiCaprio and advertised during the Super Bowl and the Oscars and on the
hoods of NASCAR race cars.”19
Prior to August of 2016, e-cigarettes fell blissfully outside of the FDA’s
tobacco regulatory powers. In a climate of little to no regulation in the
United States, “more than 8,500 vape shops have sprung up in strip malls and
stand alone stores across the country.”20 Much of the industry’s “early
success comes thanks to [its] near complete freedom from regulation, which
has allowed dozens of small players to flourish.”21 Vape shops are not set up
like typical retail stores; instead, they resemble bars or cafés. Users can enter
with their vape pens and chat with the staff, sample new flavors, and
socialize at the bar.
As the market has evolved, e-cigarettes have become part of a youthful
cultural movement often referred to as “vape culture.”22 Vaping is seen as a
social activity rather than a therapeutic one; in fact, “several studies
demonstrated the recreational element of e-cigarette use. In one study that
included two surveys of more than 3,500 e-cigarette users, only one showed
a marginally significant correlation between use and a quit attempt in the last
three months.”23 Another study found that among university students, there
was “no established association between e-cigarette use and intention to quit
smoking.”24 According to the Centers for Disease Control and Prevention
(CDC), e-cigarette use in the United States by “tweens and teens tripled in
2014 to 13.4% from 4.5% in 2013.”25 Besides the flavors, another large
appeal for young consumers is the amount of vapor e-cigarettes produce. Ecigarettes “produce much more vapor, especially when adjusted to operate at
high temperatures, than conventional cigarettes, which helps

18

Countries Vindicate Cautious Stance on E-Cigarettes, supra note 1, at 857.
Gray, supra note 9.
20
FDA Cloud Hangs Over Vape Shops, supra note 13 (discussing the potential chilling
effects and monetary losses resulting from FDA regulations).
21
Gray, supra note 9.
22
In 2014, Oxford Dictionaries announced ‘vape’ as its international Word of the Year
2014. Research “conducted by Oxford Dictionaries editors reveals that the use of the word
vape in 2014 has more than doubled” compared with use in 2013. See VAPE is Named
Oxford Dictionaries Word of the Year in 2014, OXFORD DICTIONARIES, http://blog.oxforddict
ionaries.com/press-releases/vape-named-oxford-dictionaries-word-year-2014/.
23
Rahman et al., supra note 4, at 6.
24
Id.
25
Jilian Mincer, As Youth Vaping Rises, Teens Cite the Allure of Tricks, REUTERS (May 1,
2015), http://www.reuters.com/article/us-ecigarettes-teens-tricks-insight-idUSKBN0NM4902
0150501.
19
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facilitate . . . vapor tricks.”26 Vapers hold what are called cloud competitions
where they compete to perform the best tricks and create the biggest and
densest vapor clouds.27 Thousands of YouTube and Instagram videos are
posted daily “demonstrating expert vaping and how to perform tricks.”28
E-cigarette liquid, sometimes called “e-liquid,” “juice,” “vape juice,” or “ejuice” by users, comes in many different flavors labeled and marketed for
aesthetic appeal. A recent study indicated that e-liquids are “marketed in 7764
unique flavours.”29 Ripe Vapes, a handcrafted line of e-cigarette liquids,
features flavors such as Pear Almond (“envoking the polished pastries of
Europe”) and Coconut Thai (“smooth coconut, rich and slightly sweet
followed by after notes of fresh thai basil and bright lemongrass”).30 Most
lines are marketed toward a younger, hipper demographic with labels featuring
UFOs, edgy graphics, and bearded hipsters. Even the names and flavors of the
liquids are edgy and stylish with flavors modeled on well-liked sweets. For
example, “Gush” draws its inspiration from the highly popular gummy candy
Gushers. “Rolly” is based on the equally popular Fruit Roll-Up children’s
snack, and “I LOVE Donuts” tastes like the delicious and sugary pastry.31
Because e-cigarettes have not been on the market for long, there is limited
data on use by younger demographics such as teens and adolescents.
However, the flavors and labeling certainly suggest the industry is targeting a
younger market. In 2011 and 2012, the National Youth Tobacco Survey
“reported a doubling in e-cigarette lifetime use (ever used) from 2011 to
2012 for both [American] middle school (1.4% to 2.7%) and high school
(4.7% to 10.0%) students.”32 The survey also reported “current use (in the
past 30 days) of e-cigarettes also doubled from 0.6% in 2011 to 1.1% in 2012
among middle school students and 1.5% in 2011 to 2.8% in 2012 among
high school students.”33 In 2014, the CDC issued a finding that “current ecigarette use among middle and high school students tripled from 2013 to
2014.”34 That means that current e-cigarette use, defined as using an e26

Id.
Id.
28
Id.
29
Electronic Nicotine Delivery Systems, supra note 17, at 9.
30
RIPE VAPES: HANDCRAFTED JOOSE, http://ripevapes.com.
31
ELIQUID.COM, https://www.eliquid.com/products/alien-piss-by-bomb-sauce-e-liquid.
32
Rebecca J. Williams & Rebecca Knight, Insights in Public Health—Electronic
Cigarettes: Marketing to Hawai‘i’s Adolescents, 74 HAW. J. MED. & PUB. HEALTH 66, 66
(2015) (evaluating the emerging phenomenon of e-cigarette use and the potential public health
threat the trend poses to Hawaii’s youth).
33
Id.
34
Press Release: E-Cigarette Use Triples Among Middle and High School Students in Just
One Year, CDC (Apr. 16, 2015, 1:00 PM), http://www.cdc.gov/media/releases/2015/p0416-ecigarette-use.html. The CDC issued a press release discussing what it had learned in surveys
27
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cigarette on at least one day in the past thirty days, among high school
students has risen from “approximately 660,000 to 2 million students.”35
The CDC also noted that “this is the first time since the survey started
collecting data on e-cigarettes in 2011 that current e-cigarette use surpassed
current use of every other tobacco product overall, including conventional
cigarettes.”36 To emphasize the risk of teen nicotine use, the CDC also
pointed to a 2012 Surgeon General’s Report that “found that about 90
percent of all smokers first tried cigarettes as teens; and that about three of
every four teen smokers continue into adulthood.”37
C. Health Effects
Scientific studies on e-cigarettes are relatively limited given the newness
of the product coupled with “the lengthy lag time for onset of many diseases
of interest, such as cancer, conclusive evidence about the association of
ENDS use with such diseases will not be available for years or even
decades.” However, “the limited testing has revealed wide variations in the
nature of the toxicity of contents and emissions.”38
Nicotine is highly addictive, more so than “harder” drugs like heroin or
cocaine.39 Withdrawal symptoms of those attempting to quit a nicotine
addiction are “psychologically damaging; they feel anxious, depressed,
irritable, bored, and unable to focus.”40 Those who have used both heroin
and nicotine report it is harder to kick a nicotine habit.41 Nicotine plays a
“role in neuro-degeneration and there is evidence of brain development
problems in children and fetuses that have been exposed to nicotine.”42
Inhalation of nicotine itself is addictive, “can have adverse effects during

conducted on e-cigarette use among American middle and high school students. The CDC
reported a huge increase in just one year’s time, and recommended that action be taken to
reduce the potential harm due to this rise in use. Notably, the survey also found that there was
a decided increase in hookah smoking (roughly double). However, the rise of both hookah
and e-cigarette use offset declines in use of more traditional products such as cigarettes and
cigars. The CDC urged the FDA to increase categories of tobacco regulation to include both
hookah and e-cigarette products. Id.
35
Id.
36
Id.
37
Id.
38
Electronic Nicotine Delivery Systems, supra note 17, at 3–4.
39
Eighty-five percent of smokers who attempt to quit will relapse within a week. Is
Nicotine Addictive?, NAT’L INST. ON DRUG ABUSE (July 2012), http://www.drugabuse.gov/pu
blications/research-reports/tobacco/nicotine-addictive.
40
Gray, supra note 9.
41
Id.
42
Countries Vindicate Cautious Stance on E-Cigarettes, supra note 1, at 856.
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pregnancy and may contribute to cardiovascular disease.”43 Additionally,
nicotine “may function as a ‘tumor promoter,’ ” and “seems involved in
fundamental aspects of the biology of malignant diseases, as well as of
neurodegeneration.”44 This evidence is at least sufficient enough, according
to the World Health Organization (WHO), “to caution children and
adolescents, pregnant women, and women of reproductive age about ENDS
use because of the potential for fetal and adolescent nicotine exposure to
have long-term consequences for brain development.”45 Even those e-liquids
that do not contain nicotine may have serious long-term health consequences.
Evidence based on the assessment of chemical compounds in the liquids used
in, and aerosol produced by, ENDS indicate the presence of cytotoxicity and
carcinogenic compounds. These compounds were found to differ greatly
across products, which may present as a logical regulatory target.
In addition to the health risks posed by inhalation, nicotine can also be
harmful if ingested or if it comes into contact with the skin.46 This threat can
pose a particular risk to children who may accidentally ingest e-liquid if
packaging is not childproofed. According to available reports from the
United States and the United Kingdom, “the number of reported incidents
involving nicotine poisoning has risen substantially as the use of ENDS has
increased. The actual number of cases is probably much higher than those
reported.”47
The WHO Study Group on Tobacco Product Regulation concluded:
The existing evidence shows that ENDS aerosol is not merely
“water vapour” as is often claimed in the marketing for these
products. ENDS use poses serious threats to adolescents and
fetuses. In addition, it increases exposure of non-smokers and
bystanders to nicotine and a number of toxicants.
Nevertheless, the reduced exposure to toxicants of wellregulated ENDS used by established adult smokers as a
complete substitution for cigarettes is likely to be less toxic for
the smoker than conventional cigarettes or other combusted
tobacco products. The amount of risk reduction, however, is
presently unknown.48

43
44
45
46
47
48

Electronic Nicotine Delivery Systems, supra note 17, at 3.
Id.
Id. at 4.
Id.
Id.
Id. at 5.
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D. Marketing
Unsurprisingly, marketing of e-cigarettes has grossly outstripped and
preceded any regulatory oversight. According to a study done by Kantar
Media, “in the first quarter of 2013, e-cigarette spending on advertising rose to
$15.7 million in the U.S., up from $2 million in the same period” in 2012.49
Advertising data from the study “shows placements . . . on mainstream media,
on cable stations--e-cigarettes, unlike regular cigarettes, can advertise on TV
[in the US]--as well as in magazines (including Time).”50 Some of the
innovative marketing techniques, such as endorsements by millennial
YouTube vapers, may require creative regulation to combat. According to the
WHO:
ENDS are being marketed to consumers in many media and
forms, including television commercial, sports and cultural
sponsorship, celebrity endorsement, social networking, online
advertising, point-of-sale displays, pricing strategies, and
product innovation. Some marking clearly emulates the very
successful tobacco advertising asserting an independent
identity and a lifestyle choice, aligning oneself with celebrities,
fashionable and youthful places and activities. Some ENDS
are marketed not only as socially acceptable but as socially
superior. Unsubstantiated or overstated claims of safety and
cessation are frequent marketing themes aimed at smokers.
Some ENDS marketing also promotes long-term use as a
permanent alternative to tobacco, and a temporary one in
public places where smoking is banned. ENDS marketing
activities have the potential to glamorize smoking and
attracting children and nonsmokers even if those are
unintentional results.51
On the issue of sweetened flavorings of e-liquids, the WHO report on ecigarettes noted, “expert opinion indicates that candy-like flavours could
entice youths to experiment with ENDS and could also facilitate the
development of tobacco dependence by enhancing the sensory rewards of
ENDS use.”52 Historically, “the tobacco industry’s internal documents
suggest that flavouring agents have played an important role in the industry’s
49
50
51
52

Gray, supra note 9.
Id.
Electronic Nicotine Delivery Systems, supra note 17, at 9.
Id.
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targeting of children and youth, and there is a concern that they could play
the same role in the uptake of ENDS in these age groups.”53 Minors
traditionally receive greater protection through regulation because they are
seen as a vulnerable demographic that may be more easily swayed through
advertising.54 Other industries such as alcohol and tobacco have seen their
marketing subject to stringent regulation in relation to minors.55 However, in
the age of social media and the internet, regulation here could be a bit tricky
as e-cigarette vendors often exclusively sell and market online, with heavy
emphasis on social media advertising and endorsement.56
E. Existing Regulation
1. World Health Organization Regulatory Framework
The World Health Organization Framework Convention on Tobacco
Control (WHO FCTC) became effective in February 2005.57 The WHO
FCTC is the first global public health treaty.58 The WHO FCTC:
was developed by countries in response to the globalization of
the tobacco epidemic. It aims to tackle some of the causes of
that epidemic, including complex factors with cross-border
effects, such as trade liberalization and direct foreign
investment, tobacco advertising, promotion and sponsorship
beyond national borders, and illicit trade in tobacco products.59
Parties to the WHO FCTC have implemented recommended measures such
as increased pricing and tax measures on tobacco products as well as nonprice measures such as restricting smoking in public places like public
transportation systems and workplaces and regulating “the contents and
emissions of tobacco products and the methods by which they are tested and
53

Id.
See generally Roscoe B. Starek, III, The ABCs at the FTC: Marketing and Advertising to
Children, FED. TRADE COMMISSION (July 25, 1997), https://www.ftc.gov/public-statements/19
97/07/abcs-ftc-marketing-and-advertising-children.
55
Id.
56
Tim K. Mackey, Angela Miner & Raphael E. Cuomo, Exploring the e-cigarette ecommerce marketplace: Identifying Internet e-cigarette marketing characteristics and
regulatory gaps, 156 DRUG AND ALCOHOL DEPENDENCE 97, 99 (2015).
57
The WHO Convention on Tobacco Control: An Overview, WHO FRAMEWORK ON
TOBACCO CONTROL 1, 1 (Jan. 2005), http://www.who.int/fctc/about/WHO_FCTC_summary_
January2015.pdf?ua=1.
58
Id.
59
Id.
54
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measured.”60 The FCTC “commits Parties not only to preventing and
reducing tobacco consumption and exposure to tobacco smoke but also
preventing and reducing nicotine addiction independently from its source.
Therefore, while medicinal use of nicotine is a public health option under the
treaty, recreational use is not.”61 The WHO FCTC specifically addressed the
issue of electronic cigarettes in a conference held in Moscow in 2014.62 The
WHO FCTC examined “emerging evidence on the health impacts of
electronic nicotine delivery systems (ENDS) use . . . [identified] options for
their prevention and control,” and presented its findings at this conference.63
The Conference of Parties (COP), a governing body of the international
treaty comprising of 179 countries, “decided that tax rates should be
monitored, increased, and adjusted annually, taking inflation and income
growth into account, as tobacco taxation is a known means of reducing
smoking.”64 Armando Peruga, a doctor of medicine and public health who
works in the area of tobacco control for the World Health Organization,
spoke on behalf of the WHO in respect to e-cigarette regulation.65
The WHO FCTC outlined certain specific regulatory options that they
deemed prudent in the e-cigarette industry. The first is regulating health
claims that manufacturers and third parties can make on behalf of electronic
cigarettes.66 Specifically, the FCTC advised that manufacturers of electronic
cigarettes should be prohibited “from making health claims for ENDS,
including that ENDS are smoking cessation aids, until manufacturers provide
convincing supporting scientific evidence and obtain regulatory approval.”67
As with cigarettes, the FCTC also recommended regulation of the use of
electronic cigarettes in public places to reduce harms associated with second
hand smoke inhalation, particularly in indoor areas.68
Another recommended regulatory option is the regulation of advertising,
promotion and sponsorship while paying particular care to protect nonsmokers and children. The FCTC recommended, at a minimum, that
regulation should require advertisements of e-cigarettes clearly state that the
product contains nicotine or may be used with nicotine solutions; that they
should not target or appeal to non-smokers; that they should not implicitly or
60

Id. at 2–3.
Electronic Nicotine Delivery Systems, supra note 17, at 10.
62
Id. at 1.
63
Id.
64
Public Health Round-up, 92 BULL. OF THE WORLD HEALTH ORG. 776, 777 (Nov. 2014),
http://www.who.int/bulletin/volumes/92/11/14-011114.pdf.
65
Countries Vindicate Cautious Stance on E-Cigarettes, supra note 1, at 857.
66
Id.
67
Electronic Nicotine Delivery Systems, supra note 17, at 11.
68
Id.
61
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explicitly target minors; that they should encourage smoking cessation; that
they contain nothing that could be expected to promote the use of tobacco
products; that they use no terms that may confuse or associate the product
with tobacco; that they include factual health information that does not
distort risk factors; and that they not contain health or medicinal claims
unless the product is specifically licensed for those purposes. Additionally,
the FCTC concluded that in solutions that contain nicotine, the regulations
should require a clear statement of the addictive nature of nicotine and that
the electronic cigarette is a nicotine delivery device as well as prohibit all
suggestions that electronic cigarettes have positive qualities as a consequence
of the addictive nature of the product.69 The FCTC recommends protection
from vested commercial interest providing that “[t]ransparency should be
required from ENDS and tobacco companies advocating for and against
legislation and regulation, both directly and through third parties.”70
Further, the FCTC recommends that regulations should mandate health
warnings, prohibit sales to minors and that governments should strengthen
their existing tobacco surveillance and monitoring systems.71 Perhaps most
practically, the FCTC advocates for regulation of product design and
information.72 Specifically, electronic cigarettes should be regulated to
minimize the “content and emission of toxicants” as much as possible; ban
candy-like flavors that would appeal to minors; impede product alteration to
use of other drugs such as cannabis oil; standardize nicotine delivery levels;
mandate nicotine quality levels; and require registration of manufacturers
and importers with regulatory agencies.73
2. Existing Regulation
The regulation of e-cigarettes is first determined by the status the country
gives to the products. There are three possible regulatory categories ecigarettes fall into—medical or pharmaceutical device, tobacco product, or
consumer product. Some countries, such as Singapore, have ratified or
otherwise formally approved the WHO FCTC and are working within the
guidelines set down by the WHO.74 Within the European Union generally,
regulation has “progressed independently with a hybrid approach; in
February 2014, the European Parliament voted to regulate e-cigarettes as
69
70
71
72
73
74

Id. at 12.
Id.
Id. at 13.
Id.
Id.
See generally id. at 1 n.2.
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tobacco products . . . [except] those claiming therapeutic benefit as medicinal
devices.”75 This regulation “will include a restriction on purchase age to a
minimum of 18, close limitations on advertising and marketing including
health warnings on packaging and the imposition of manufacturing
standards.”76
Spanish health officials have elected to classify e-cigarettes as a “regular
consumer product” but, “specific regulation is applicable to nicotine
containing e-cigarettes.”77 Likewise, France has enacted regulations that
limit levels of nicotine in e-liquid and require safe packaging but otherwise
classify e-cigarettes as a “regular consumer product.”78 In contrast, the
United Kingdom regulates e-cigarette products containing nicotine as
medical devices.79 U.K. public health officials reason that “even a small
dose of nicotine has pharmacological effects and that there is too much
scientific uncertainty to establish a minimum threshold, that all nicotinecontaining e-cigarettes, regardless of the level of nicotine, should be
considered pharmaceuticals.”80 Similarly in Belgium, “nicotine-containing
e-cigarettes, as well as other e-cigarettes accompanied by a medical claim,
are considered pharmaceuticals in need of a marketing authorization.”81
Vaping has quickly become trendy in Malaysia with one vaping
association reporting at least 500,000 Malaysians are vaping, while another
reports that the number is closer to a million.82 The Malaysian E-Vaporizers
and Tobacco Alternatives Association reports that “Malaysia’s vaping
market is only second to that of the United States and was worth and
estimated RM2.8 billion (US$639 million)” as of 2014.83 E-liquids in
Malaysia are even offered in regional flavors such as mango lassi, honeydew,
lychee, and bandung.84 In October of 2015, the Malaysian Cabinet
considered following Singapore’s lead of implementing an outright ban on e75

Rahman et al., supra note 4, at 6.
Id.
77
Egenie Syx, The Case of the Electronic Cigarette in the EU, 21 EUR. J. HEALTH L. 161,
170–71 (2014) (analyzing electronic cigarette regulations within the framework of the
European Union).
78
Id. at 172–73.
79
Id. at 172.
80
Id.
81
Id. at 174.
82
Sumisha Naidu, Malaysia to Regulate Sale of E-cigarette Liquids, CHANNEL NEWSASIA
(Nov. 9, 2015), http://www.channelnewsasia.com/news/asiapacific/malaysia-to-regulate-sale/
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cigarettes as the Minister of Health “has been concerned about the long-term
health risks [of e-cigarettes] and fears that people who never smoked before
were taking up vaping for fun.”85 The Cabinet decided against a ban, but
Malaysia’s Director General of Health announced that e-liquid that contains
nicotine will be regulated under the Poisons Act; therefore “the sale of eliquids containing nicotine can only be supplied by licensed pharmacists and
registered medical practitioners.”86 After the announcement, Malaysia’s
Health Ministry began carrying out raids, reportedly raiding “more than 300
stores selling electronic cigarettes nationwide, raising howls of complaints
from the store owners at the surprise move to seize their goods.”87 The
Director-General of Health said that “a study by the National Poison Centre
at the Science University of Malaysia found that 40mg of nicotine contained
in 10ml of vape liquids could instantly kill an adult person,” and therefore
the product need to be subject to strict regulation.88
Singapore has banned the sale of e-cigarettes entirely under the Tobacco
(Control of Advertisements and Sale) Act.89 Singapore’s Ministry of Health
shares:
the WHO and UK’s concerns over the lack of efficacy and
safety of e-cigarettes, and their effects on long term health.
Until there is strong, conclusive evidence supporting the safety
and efficacy of e-cigarettes, [the] Ministry will continue to
adopt a prudent approach and prohibit the import, distribution,
and sale of e-cigarettes in Singapore.90
Dr. Lam Pin Min, speaking on behalf of Singapore’s Ministry of Health,
stated that while “electronic cigarettes (e-cigarette) have been marketed as
safer, healthier alternatives to tobacco smoking, and as smoking cessation
devices . . . their effectiveness in helping smokers quit tobacco use has yet to
be demonstrated . . . .”91 The Ministry notes:
85
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e-cigarettes that claim to be smoking cessation products to help
smokers quit tobacco use should demonstrate their safety and
effectiveness with the same level of scientific rigor required for
approved Nicotine-Replacement Therapies under the Medicines
Act. As yet, there have been no applications to register ENDS as
smoking cessation therapies.92
A study conducted by the Health Sciences Authority in Singapore “found
poor consistency between actual nicotine in e-cigarettes and the amount
labelled.”93
However, although Singapore has banned import and
distribution of e-cigarettes, many report they can still be obtained illegally
through local online channels.94 Nevertheless, e-cigarettes have largely not
caught on in Singapore like they have in other markets suggesting the ban
has been successful overall. However, Singapore does not have a ban on
traditional cigarettes which means, “[i]t’s a lot easier for teenagers to get
traditional cigarettes” in Singapore than electronic cigarettes.95
Likewise, in Australia, “the regulatory process has not been subject to the
same debate, because the Therapeutic Goods Administration (TGA)
essentially banned e-cigarettes” when the initially came on the market.96 The
TGA “prohibits importation, supply and sale of goods claiming therapeutic
benefit that it has not approved, which applies to e-cigarettes marketed as
smoking cessation aids.”97 To address e-cigarette products not marketed as
such, “it also bans the sale of goods not containing tobacco that are designed
to resemble tobacco products, whether the resemblance is in the product
itself or its packaging.”98
Regulation of e-cigarettes will be handled in the United States by the Food
and Drug Administration (FDA), which is statutorily authorized to regulate
food and drug safety by Congress. Initially, the FDA attempted “to regulate ecigarettes as drug-delivery devices,” which would have placed them under a
relatively stringent regulatory regime.99 However, “this was blocked by
lawmakers because the products made no therapeutic claim, arguing they
should instead be regulated as tobacco products because they contained
tobacco-derived nicotine.”100 Regulating e-cigarettes as a tobacco product
92
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rather than a drug-delivery device gives the FDA much less power in the
regulatory structure. The FDA’s Center for Tobacco Products (CTP), which
regulates cigarettes, cigarette tobacco, roll-your-own tobacco, and smokeless
tobacco, “held three public workshops to obtain information on electronic
cigarettes and the public health” in addition to receiving public comments until
July 2015.101 The FDA then issued a “proposed rule that would extend the
agency’s tobacco authority to cover additional products that meet the legal
definition of a tobacco product, such as e-cigarettes.”102 In May of 2016 the
FDA finalized a rule, effective August 8, 2016, that includes e-cigarettes and
their nicotine vapor solutions in their regulation of tobacco products. Whereas
before e-cigarettes escaped the FDA’s regulatory scheme, they can now
regulate e-cigarettes using the same methods they have employed to regulate
tobacco, such as restrictions on marketing and sales to minors. The new rule
forbids the sale of e-cigarettes and vapor solutions to minors, forbids giving
away vapor samples, and forbids the sale of e-cigarette products in vending
machines. Allowing a grandfather period of two years, manufacturers will
now be required to include ingredient labels on their vapor solutions and report
any potentially harmful constituents in the products.
To understand the e-cigarette regulation climate in the United States, a
brief understanding of U.S. tobacco regulation is necessary. The FDA did
not receive authority to regulate tobacco until the passage of the Tobacco
Control Act by Congress in 2009.103 The FDA had long fought for the
authority to regulate the industry of a consumable product with such a
substantial impact on the health and welfare of U.S. citizens. Before 1996,
the tobacco industry was regulated solely through state law and some limited
congressional statutes. Most of these laws were prohibitions on the sale of
tobacco products to minors.
Federal regulations were passed relating to advertising of cigarettes in the
1960s and 1970s. In 1965, Congress passed the Federal Cigarette Labeling
and Advertising Act, which required cigarette cartridges to be labeled with a
health warning.104 In 1970, the Public Health Cigarette Smoking Act was
passed, banning cigarette ads on the radio and television and requiring a
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Surgeon General Warning label to be affixed to all cigarette cartridges.105 In
1996, the FDA made an attempt to assert authority over tobacco products.
However, the tobacco companies sued. The case went before the United
States Supreme Court in FDA v. Brown & Williamson Tobacco Corp.,106
Ultimately, the Supreme Court decided that the FDA had no statutory
authority to regulate the tobacco industry.107 In 2007, the issue went before
the Fifth Circuit in Brown v. Brown & Williamson Tobacco Corp. The case
was largely related to the legality of marketing “light” cigarettes.108 The
tobacco companies appealed the decision of the district court, which ruled in
favor of the appellee’s claims under the Louisiana Unfair Trade Practices and
Consumer Protection Act.109 The companies argued that federal law should
trump state law.110 The Fifth Circuit agreed and found in favor of the
tobacco companies.111 In response to these court rulings, in 2009, Congress
passed the Family Smoking Prevention and Tobacco Control Act, which
finally designated specific regulatory powers to the FDA.112
The Tobacco Control Act “makes clear that the FDA’s role is to regulate
and protect the public health . . . .”113 The Act “puts in place specific
restrictions on marketing tobacco products to children and gives FDA
authority to take further action in the future to protect public health.”114 The
provisions include bans on sales to minors, public access vending machine
sales, sales of packages of fewer than twenty cigarettes, tobacco-brand
sponsorships of sport and entertainment events or other social or cultural
events, free giveaways of sample cigarettes and brand name non-tobacco
promotional items.115 There are several restrictions under the Act, the FDA
cannot: “[r]equire prescriptions to purchase tobacco products[, r]equire the
105
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reduction of nicotine yields to zero[, b]an face-to-face sales in a particular
category of retail outlets[, or b]an certain classes of tobacco products.”116 The
Act requires smokeless tobacco products (snuff, chewing tobacco, snus) and
advertisements to furnish visible warning to buyers and consumers.117 Every
smokeless tobacco package and advertisement must contain one of the
following warnings: “ ‘WARNING’: This product can cause mouth cancer.
This product can cause gum disease and tooth loss. This product is not a safe
alternative to cigarettes, [or s]mokeless tobacco is addictive.”118 Additionally,
the warnings must cover at least 30% of two sides of the packaging and at least
20% of an advertisement.119 The Act requires that any claims made of
“modified risk” products be supported by scientific evidence; this affects
cigarette products labeled “natural,” “light,” “low,” “mild,” etc.120
Additionally, the Act requires detailed disclosure of all ingredients contained
in tobacco products, requires registration and inspection of tobacco companies,
allows for the FDA to implement standards on tobacco products to protect
public health (regulating nicotine levels or levels of other chemicals), bans
cigarettes with characterizing flavors (excluding menthol and tobacco), and
funds FDA regulation through a tax on tobacco products (based on market
share).121 Currently, the FDA Center for Tobacco Products also regulates
electronic cigarettes much the same way as other tobacco products.122
3. Regulation and Trade Agreements
How a country ultimately chooses to classify the product has implications
not only nationally but may affect international trade agreements as well.
For example, the Trans-Pacific Partnership (TPP) Agreement123 has a
116
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proposed provision relating to the handling of tobacco regulation between
countries participating in the agreement.124 Michael Froman, United States
Trade Representative stated in reference to the TPP Tobacco Proposal:
Developed following extensive consultations with Congress
and with a wide range of American stakeholders—from health
advocates to farmers, representing many views on whether and
how to address tobacco-related health policy measures in a
trade agreement—this proposal will, for the first time in a trade
agreement, address specifically the public health issues
surrounding tobacco—preserving the ability of the United
States and other TPP countries to regulate tobacco and to apply
appropriate public health measures, and bringing health and
trade officials together if tobacco-related issues arise—while
remaining consistent with our trade policy objectives of
negotiating a comprehensive agreement that does not create a
precedent for excluding agricultural products. We will
continue to keep our Congressional partners and stakeholders
informed and involved as we negotiate this challenging and
important issue with TPP partners, whom will be taking into
account the same range of concerns.125
Bill Corr, Deputy Secretary of the Department of Health and Human
Services, issued the following statement on the issue:
HSS believes the proposed tobacco language in the TransPacific Partnership trade negotiation will make a difference for
tobacco control and public health efforts.
The U.S.
Government seeks to include this language because tobacco is
a unique product—it is highly addictive, always harmful to
human health, and the single most preventable cause of death
in the world. Recognizing these facts about tobacco through
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the TPP will represent an important step forward for public
health in the international trade community.126
This effort to be attentive to public health regulations of other countries is
a turning point in international trade agreements and U.S commerce
objectives. The U.S. Chamber of Commerce has been known to try to
dissuade and discourage other countries from implementing any anti-tobacco
legislation and regulation. Chief executive of the chamber, Thomas
Donohue,
has transformed the chamber into a powerful lobbying force, an
evolution most starkly epitomized by its aggressive advocacy
for tobacco. While the organization represents a variety of
industries, its strategy has been a boon for cigarette makers,
which have relied heavily on the chamber to push their agenda
at home and abroad.127
In a reprehensible policy decision, the chamber has begun “pressuring
governments around the world to turn back antismoking legislation”
including “an attack on excise tax in the Philippines, cigarette advertising
bans in Uruguay and restrictions on smoking in public places in Moldova.”128
In September 2013, the Chamber sent a letter to the prime minster of
Jamaica voicing concerns over tobacco regulations requiring graphic
labeling, claiming these labels “ ‘are not effective’ and create ‘unnecessary
obstacles to trade.’ ”129 However, functionally under the TPP, it seems as
though any public health regulation promulgated in relation to e-cigarettes
will be respected.
III. ANALYSIS
Although public health organizations such as the WHO have strongly
advocated for clamping down on e-cigarette consumption through regulation,
there are civil liberty advocates and laissez faire capitalists who argue that
the market is better left largely unregulated. While the e-cigarette market in
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the United States was not regulated prior to 2016, it served as an example of
a successful, unregulated market in which small businesses were able to
flourish because they faced few barriers to trade. Public health specialists
have come down on the side of e-cigarettes as a powerful harm reduction
tool. Notably, after the WHO issued their report, “53 international health
experts wrote a joint letter urging the WHO’s general director to ‘resist the
urge’ to ‘control and suppress’ electronic cigarettes by classifying them as
equivalent to cigarettes for purposes of regulation.”130
The director of the CDC, Thomas Frieden, pointed out that while there is
still much we do not know about e-cigarettes, “we do know quite a bit:
foremost, that they don’t combust tobacco and so do not produce carcinogenic
tars and disease-producing gases, including carbon monoxide . . . [t]his
advantage makes vaping at least 95 percent safer than smoking tobacco,
according to toxicologists.”131 Therefore, proponents argue these products
should be at least as available as their more harmful counterparts, if not more
so. Those who champion e-cigarettes call for a regulatory scheme which will
only minimally tax e-cigarettes so that smokers will be incentivized to make
the switch, but most still agree that e-cigarettes should be kept out of the hands
of children and teenagers.132 Sally Satel, a psychiatrist specializing in
addiction medicine, has argued in favor of less e-cigarette regulation, in
particular the stance taken by the WHO. She argues that public health officials
“[m]isrepresenting the facts about e-cigarettes and instilling doubt about their
superiority to cigarettes . . .” only hinders progress, keeping “smokers inhaling
deadly toxins, . . . [because], [a]fter all, why give up the combustible devil you
know if vaping is just as bad?”133
As far as the potential harm to younger generations, e-cigarette
proponents argue that there is “no sign of a gateway effect” from e-cigarettes
to traditional tobacco products.134 In the United States, while there are “more
kids vaping each year, teen cigarette consumption . . . continues to fall.”135
However, while kids may not be switching from e-cigarettes to traditional
combustible cigarettes, they are still being hooked on nicotine where they
probably were not before. Thomas Friedan lamented, “ ‘[t]his is another
generation being hooked by the tobacco industry’ . . . .”136
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Some public health experts argue that in developing countries where
cigarette smoking is endemic, e-cigarettes should be heavily promoted rather
than restricted. China is often cited as an example of a country where vaping
should be encouraged. China reports that one million deaths are caused each
year by tobacco products consumption and the death toll is projected to rise
in the coming years.137 In China, where smoking has become a pervasive
element of social culture, if just “1 percent of China’s smoking population
turned to e-cigarettes, it would mean a market of about 3.5 million ecigarette users” and a massive reduction in harm for the country.138
However, while vaping may be a positive force in a country such as China,
where public health efforts to combat smoking have been virtually
nonexistent (“[o]nly 25% of Chinese adults have a comprehensive
understanding of the health risks of smoking . . .”139), it still may pose a
greater risk in countries such as the United States who have significantly
reduced their rates of smoking in the last twenty years. In Singapore, more
than 1,900 people are still killed annually due to tobacco related diseases.140
Some would argue a better strategy for their country would be to allow ecigarettes, at least in a therapeutic context, rather than ban them outright, to
reduce some of this tobacco related harm. Malaysia too might benefit from
the harm reduction side of e-cigarettes as their population still sees more
deaths due to cigarettes than other middle-income countries.141
IV. CONCLUSION
Given the massive investment Big Tobacco has made in the e-cigarette
industry and the growing social vaping movement, it seems likely most
countries will regulate e-cigarettes as a tobacco product, which will give way
to stricter regulations than with an ordinary consumer product but less strict
than one would see with a medical device.
E-cigarette regulation should be tailored to the needs of the specific
country. The WHO framework better suits countries who have already
launched public health campaigns against tobacco. These countries that have
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already reduced smoking in their population should focus on regulation that
will restrict access for younger markets. While e-cigarettes have a legitimate
use as a smoking cessation device, if they continue to addict new generations
of users who would have otherwise remained nicotine independent, the
relative good of the product would not outweigh the potential societal harm.
The most prudent regulatory scheme would be one which would allow the
product to remain easily available to those who are using it for a legitimately
therapeutic purpose. Regulation should be heavily focused on reducing
consumption of the product by children and teenagers. In this respect, the
WHO framework serves as a functional and well thought out model for
regulation. Less developed countries, such as China, may have populations
with much higher rates of smokers who are less educated about the health
risks of smoking. In these, countries while e-cigarettes should of course be
regulated for quality and product safety, their use should be incentivized
through regulation.
The electronic cigarette market is rapidly growing and clearly poses at
least some risks to public health. In order to mitigate these risks, it is
important that governments put regulatory schemes into place that
appropriately respond to the risks posed by tobacco products in their country.
At a minimum, regulation of the products themselves that put in place
standards and quality control measures, as well as consumer labeling and
packaging regulations, should be put into effect.

